Zyvex Continues to Exceed Sales Expectations

Oct 21, 2004, 01:00 ET from Zyvex Corporation

    RICHARDSON, Texas, Oct. 21 /PRNewswire/ -- Zyvex today announced financial
 results for its fiscal third quarter 2004.  The Texas company continues its
 business gains with eight consecutive quarters of sales growth and expansion
 of its global sales reach.  Executives anticipate that 2004's total revenue
 will exceed $8 million, which would represent a 90+ percent increase over
     "I continue to be extremely pleased with our financial results," stated
 Zyvex's CFO Timothy M. Gilmore.  "During the month of September, we recorded
 our largest single month of customer orders booked, as well as net sales
     Founded in 1997, Zyvex reported its first revenues in 2001, grossing only
 $150,000.  Company revenues grew to $1.2 million in 2002 and $4.5 million in
 2003.  Gilmore anticipates that the company will achieve cash-flow break-even
 by Q4 2005, and become bottom-line profitable in 2006.
     This announcement follows Zyvex's continued worldwide sales and marketing
 expansion into China, France, Germany, Italy, Japan, Korea, Malaysia, Poland,
 Singapore, Switzerland, Taiwan, Thailand, the United Kingdom, and Vietnam
 through alliances with Keithley Instruments, Inc., Caltron, Pte., and L.O.T.-
 Oriel.  Zyvex also has numerous key alliances with industry leaders, including
 Easton Sports, FEI Company, Frost & Sullivan, MIT's Institute for Soldier
 Nanotechnologies, MANCEF, and many others.
     About the Company
     Zyvex Corporation, based in Richardson, Texas, is the first molecular
 nanotechnology company.  Zyvex's vision is to be the leading worldwide
 supplier of tools, products, and services that enable adaptable, affordable,
 and molecularly precise manufacturing.  Zyvex commercializes nanotechnology to
 address real-world applications with high growth potential.  Zyvex carries its
 scientific breakthroughs into key commercial applications in the area of
 materials, tools, and structures for major markets serving Health Care, Life
 Sciences, Telecommunications, Aerospace, Semiconductors, and Defense

SOURCE Zyvex Corporation